Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection

There is limited high-quality evidence to guide the optimal treatment of Mycobacterium kansasii pulmonary disease. We retrospectively collected clinical data from 33 patients with M. kansasii pulmonary disease to determine the time-to-sputum culture conversion (SCC) upon treatment with a standard co...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Shashikant, Boorgula, Gunavanthi D., Wang, Jann-Yuan, Huang, Hung-Ling, Howe, Dave, Gumbo, Tawanda, Heysell, Scott K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017304/
https://www.ncbi.nlm.nih.gov/pubmed/35315686
http://dx.doi.org/10.1128/aac.02320-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017304/
https://www.ncbi.nlm.nih.gov/pubmed/35315686
http://dx.doi.org/10.1128/aac.02320-21

Ejemplares similares